[HTML][HTML] The aluminium-[18F]fluoride revolution: simple radiochemistry with a big impact for radiolabelled biomolecules
SJ Archibald, L Allott - EJNMMI radiopharmacy and chemistry, 2021 - Springer
Abstract The aluminium-[18F] fluoride ([18F] AlF) radiolabelling method combines the
favourable decay characteristics of fluorine-18 with the convenience and familiarity of metal …
favourable decay characteristics of fluorine-18 with the convenience and familiarity of metal …
[HTML][HTML] Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals
S Piron, J Verhoeven, C Vanhove, F De Vos - Nuclear Medicine and …, 2022 - Elsevier
Prostate specific membrane antigen (PSMA) is an attractive target for molecular imaging of
prostate cancer and several other solid tumors because of its overexpression in prostate …
prostate cancer and several other solid tumors because of its overexpression in prostate …
18F-PSMA-11 versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer: a prospective …
K De Man, N Van Laeken, V Schelfhout, WP Fendler… - European Urology, 2022 - Elsevier
Abstract Background Fluorine-18 (18 F)-labelled prostate-specific membrane antigen
(PSMA) offers several advantages over gallium-68 (68 Ga) in terms of costs, yield …
(PSMA) offers several advantages over gallium-68 (68 Ga) in terms of costs, yield …
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
R Zhao, M Ke, J Lv, S Liu, Y Liu, J Zhang, L Xu… - European Journal of …, 2024 - Springer
Purpose This is a first-in-human study to evaluate the radiation dosimetry of a new prostate-
specific membrane antigen (PSMA)-targeted radiopharmaceutical,[18F] AlF-P16-093, and …
specific membrane antigen (PSMA)-targeted radiopharmaceutical,[18F] AlF-P16-093, and …
Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [18F]AlF-P16-093
Z Zha, SR Choi, K Ploessl, D Alexoff, R Zhao… - Bioconjugate …, 2021 - ACS Publications
Prostate-specific membrane antigen (PSMA)-targeted radioligands have played an
increasing role in the diagnosis of prostate cancer.[68Ga] Ga-P16-093 is a PSMA-targeting …
increasing role in the diagnosis of prostate cancer.[68Ga] Ga-P16-093 is a PSMA-targeting …
[HTML][HTML] Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)
Abstract The International Atomic Energy Agency (IAEA) held the 3rd International
Symposium on Trends in Radiopharmaceuticals,(ISTR-2023) at IAEA Headquarters in …
Symposium on Trends in Radiopharmaceuticals,(ISTR-2023) at IAEA Headquarters in …
Development of stabilized NTS₁R and CXCR4 PET ligands using Nω-carbamoylated arginines for label attachment
L Schindler - 2024 - epub.uni-regensburg.de
The neuropeptide neurotensin (NT), mainly expressed in the CNS and the gastrointestinal
tract, is involved in, eg, the regulation of feeding, body temperature and nociception. One of …
tract, is involved in, eg, the regulation of feeding, body temperature and nociception. One of …